Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2

Phase: N/A Priority: Normal
NCT ID: NCT02867371 Org: User:
Start: 08/31/16 End: 12/31/18 Due: 12/31/19

Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03272971 Org: User:
Start: 12/05/17 End: 01/30/19 Due: 01/30/20

Evaluation of the Archimedes™ System for Transparenchymal Nodule Access

Phase: N/A Priority: Normal
NCT ID: NCT02460120 Org: User:
Start: 07/31/15 End: 12/31/15 Due: 12/31/16

Continuing Evaluation of the LungPoint ATV System

Phase: N/A Priority: Normal
NCT ID: NCT02130128 Org: User:
Start: 04/30/14 End: 12/31/14 Due: 12/31/15

LungPoint ATV for Biopsy in Patients Undergoing Lobectomy

Phase: N/A Priority: Normal
NCT ID: NCT02130115 Org: User:
Start: 03/31/13 End: 12/31/13 Due: 12/31/14

Post-Market Optimization Study of the EMPOWER® RF Catheter to Ablate Soft Tissue Lesions in the Lung

Phase: N/A Priority: Normal
NCT ID: NCT04131777 Org: User:
Start: 12/09/19 End: 11/30/20 Due: 11/30/21